These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 4624211

  • 1. Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.
    Mason RA, Tauraso NM, Ginn RK, O'Brien TC, Trimmer RW.
    Appl Microbiol; 1972 May; 23(5):908-13. PubMed ID: 4624211
    [Abstract] [Full Text] [Related]

  • 2. Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine.
    Mason RA, Tauraso NM, Spertzel RO, Ginn RK.
    Appl Microbiol; 1973 Apr; 25(4):539-44. PubMed ID: 4633476
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serological reactions in Rhesus monkeys inoculated with the 17D strain of yellow fever virus.
    GROOT H.
    Bull World Health Organ; 1962 Apr; 27(6):709-15. PubMed ID: 13950709
    [Abstract] [Full Text] [Related]

  • 6. Studies on the sequential immunization against group B arboviruses in squirrel monkeys, cynomolgus monkeys, rhesus monkeys, and chimpanzees.
    Price WH, Casals J, O'Leary W.
    Am J Trop Med Hyg; 1974 Jan; 23(1):118-30. PubMed ID: 4204022
    [No Abstract] [Full Text] [Related]

  • 7. TWO EPISODES OF DENGUE FEVER, CAUSED BY TYPES 4 AND 1 VIRUSES, IN AN INDIVIDUAL PREVIOUSLY IMMUNIZED AGAINST YELLOW FEVER.
    CAREY DE, MYERS RM, RODRIGUES FM.
    Am J Trop Med Hyg; 1965 May; 14():448-50. PubMed ID: 14292751
    [No Abstract] [Full Text] [Related]

  • 8. Sequential immunization procedure against Group B arboviruses using living attenuated 17D yellow fever virus, living attenuated Langat E5 virus, and living attenuated dengue 2 virus (New Guinea C isolate).
    Price WH, Casals J, Thind I, O'Leary W.
    Am J Trop Med Hyg; 1973 Jul; 22(4):509-23. PubMed ID: 4352231
    [No Abstract] [Full Text] [Related]

  • 9. Immunological studies with group B arthropod-borne viruses. VI. Hemagglutination-inhibiting antibody responses to 17D yellow fever vaccine in human subjects with different degrees of complexity of pre-vaccination group B virus experience.
    Hatgi JN, Wisseman CL, Rosenzweig EC, Harrington BR, Kitaoka M.
    Am J Trop Med Hyg; 1966 Jul; 15(4):601-10. PubMed ID: 5941178
    [No Abstract] [Full Text] [Related]

  • 10. Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas.
    Monath TP, Craven RB, Muth DJ, Trautt CJ, Calisher CH, Fitzgerald SA.
    Am J Trop Med Hyg; 1980 Jul; 29(4):624-34. PubMed ID: 7406113
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
    Schlesinger JJ, Brandriss MW, Monath TP.
    Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
    [Abstract] [Full Text] [Related]

  • 12. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F, Weltzin R, Chambers TJ, Zhang ZX, Soike K, Ratterree M, Arroyo J, Georgakopoulos K, Catalan J, Monath TP.
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [Abstract] [Full Text] [Related]

  • 13. Laboratory infection with Zika virus after vaccination against yellow fever.
    Filipe AR, Martins CM, Rocha H.
    Arch Gesamte Virusforsch; 1973 Jun; 43(4):315-9. PubMed ID: 4799154
    [No Abstract] [Full Text] [Related]

  • 14. Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status.
    Scott RM, Eckels KH, Bancroft WH, Summers PL, McCown JM, Anderson JH, Russell PK.
    J Infect Dis; 1983 Dec; 148(6):1055-60. PubMed ID: 6655288
    [Abstract] [Full Text] [Related]

  • 15. YELLOW FEVER VACCINATION IN MALAYA BY SUBCUTANEOUS INJECTION AND MULTIPLE PUNCTURE. HAEMAGGLUTININ-INHIBITING ANTIBODY RESPONSES IN PERSONS WITH AND WITHOUT PRE-EXISTING ANTIBODY.
    SMITH CE, MCMAHON DA, TURNER LH.
    Bull World Health Organ; 1963 Dec; 29(1):75-80. PubMed ID: 14043754
    [Abstract] [Full Text] [Related]

  • 16. The effect of chloroquine prophylaxis on yellow fever vaccine antibody response: comparison of plaque reduction neutralization test and enzyme-linked immunosorbent assay.
    Barry M, Patterson JE, Tirrell S, Cullen MR, Shope RE.
    Am J Trop Med Hyg; 1991 Jan; 44(1):79-82. PubMed ID: 1996743
    [Abstract] [Full Text] [Related]

  • 17. Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine.
    GROOT H, RIBERIRO RB.
    Bull World Health Organ; 1962 Jan; 27(6):699-707. PubMed ID: 13950710
    [Abstract] [Full Text] [Related]

  • 18. Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.
    Niedrig M, Lademann M, Emmerich P, Lafrenz M.
    Trop Med Int Health; 1999 Dec; 4(12):867-71. PubMed ID: 10632996
    [Abstract] [Full Text] [Related]

  • 19. Yellow fever virus. I. Development and evaluation of a plaque neutralization test.
    Spector S, Tauraso NM.
    Appl Microbiol; 1968 Nov; 16(11):1770-5. PubMed ID: 4973067
    [Abstract] [Full Text] [Related]

  • 20. [The inhibiting effect of anticholera vaccination carried out simultaneously or at short intervals on yellow fever immunization. Is it real or assumed? Results of a retrospective study].
    Poveda JD, Raccurt CP, Le Fur R, M'Bailara L, Malvy JM, Le Bras M, Saliou P, Fleury HJ.
    Bull Soc Pathol Exot; 1990 Nov; 83(4):529-35; discussion 535-6. PubMed ID: 2286006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.